Ricardo M. Camelo, MD, MSc, MBA

Physician
Faculty of Pharmacy, Universidade Federal de Minas Gerais

Ricardo Mesquita Camelo, Brazilian Physician and Researcher on Rare Bleeding Disorders.
Hemophilia (hereditary and acquired), FXIII deficiency, and Glanzmann thrombasthenia
Current PhD student at two institutions: Faculty of Medicine, Universidade Federal de Minas Gerais, Brazil, and Clinical Epidemiology, Leiden University Medical Centre, the Netherlands.
Master in Physiology and Pharmacology, Universidade Federal de Minas Gerais.
Contacts: +55.31.99151.8362 and rmcamelo@hotmail.com

Presentation(s):

• PB0177 - Detection of IgG4 anti-FVIII levels as complementary test to define the ITI outcome in patients with hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0178 - High plasma levels of IgG4 anti-FVIII is the hallmark of immune tolerance failure in patients with hereditary hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0195 - Prevalence of Sporadic Haemophilia A: an updated analysis of two cohort studies

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0201 - Pathogenic variants in F8 gene - Results from the Brazilian Immune Tolerance (BrazIT) Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0215 - Efficacy, effectiveness, and safety of emicizumab for the treatment of people with hemophilia A: a systematic review

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0216 - Efficacy, effectiveness, and safety of extended half-life factor VIII products for the treatment of hemophilia A: protocol of a systematic review

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0655 - Minor surgical procedures and the outcome of immunotolerance induction: an analysis of the BrazIT Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0678 - Changing Recombinant Factor VIII for Plasma-derived FVIII during Immune Tolerance Induction: Results from the Brazilian Immune Tolerance (BrazIT) Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1146 - Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1155 - Cost of factor concentrates in the Brazilian Protocol of Immune Tolerance Induction: preliminary results of the Co$tIT Study

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM